- Home
- LSTA vs PWM Comparison
LSTA vs PWM Comparison
Compare LSTA & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- PWM
- Stock Information
- Founded
- LSTA 1980
- PWM 2018
- Country
- LSTA United States
- PWM Hong Kong
- Employees
- LSTA N/A
- PWM N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- PWM
- Sector
- LSTA Health Care
- PWM
- Exchange
- LSTA Nasdaq
- PWM Nasdaq
- Market Cap
- LSTA 20.0M
- PWM 34.6M
- IPO Year
- LSTA N/A
- PWM 2023
- Fundamental
- Price
- LSTA $2.21
- PWM $0.51
- Analyst Decision
- LSTA Strong Buy
- PWM
- Analyst Count
- LSTA 1
- PWM 0
- Target Price
- LSTA $15.00
- PWM N/A
- AVG Volume (30 Days)
- LSTA 17.1K
- PWM 372.5K
- Earning Date
- LSTA 02-27-2025
- PWM 05-06-2025
- Dividend Yield
- LSTA N/A
- PWM N/A
- EPS Growth
- LSTA N/A
- PWM N/A
- EPS
- LSTA N/A
- PWM N/A
- Revenue
- LSTA $1,000,000.00
- PWM $639,912.00
- Revenue This Year
- LSTA N/A
- PWM N/A
- Revenue Next Year
- LSTA N/A
- PWM N/A
- P/E Ratio
- LSTA N/A
- PWM N/A
- Revenue Growth
- LSTA N/A
- PWM N/A
- 52 Week Low
- LSTA $2.05
- PWM $0.45
- 52 Week High
- LSTA $4.20
- PWM $2.70
- Technical
- Relative Strength Index (RSI)
- LSTA 38.28
- PWM 31.93
- Support Level
- LSTA $2.05
- PWM $0.48
- Resistance Level
- LSTA $2.46
- PWM $0.57
- Average True Range (ATR)
- LSTA 0.20
- PWM 0.06
- MACD
- LSTA 0.01
- PWM 0.01
- Stochastic Oscillator
- LSTA 32.81
- PWM 9.13
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.